Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Predicting outcomes in melanoma

Biomarkers of response, PFS and OS for targeted and immunotherapy of stage IV melanoma

Date

04 Dec 2022

Session

Predicting outcomes in melanoma

Topics

Cancer Biology;  Immunotherapy

Tumour Site

Presenters

Ben Aissa Assma

Authors

B.A. Assma

Author affiliations

  • Oncology, HUG - Hopitaux Universitaires de Geneve, 1205 - Geneva/CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.